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We report here the characterization of a large Chinese family with maternally transmitted aminoglycoside-induced
and nonsyndromic deafness. In the absence of aminoglycosides, some matrilineal relatives in this family exhibited
late-onset/progressive deafness, with a wide range of severity and age at onset. Notably, the average age at onset
of deafness has changed from 55 years (generation II) to 10 years (generation IV). Clinical data reveal that the
administration of aminoglycosides can induce or worsen deafness in matrilineal relatives. The age at the time of
drug administration appears to be correlated with the severity of hearing loss experienced by affected individuals.
Sequence analysis of mitochondrial DNA in this pedigree identified a homoplasmic C-to-T transition at position
1494 (C1494T) in the 12S rRNA gene. The C1494T mutation is expected to form a novel U1494-1555A base
pair, which is in the same position as the C1494-1555G pair created by the deafness-associated A1555G mutation,
at the highly conserved A site of 12S rRNA. Exposure to a high concentration of paromomycin or neomycin caused
a variable but significant average increase in doubling time in lymphoblastoid cell lines derived from four symp-
tomatic and two asymptomatic individuals in this family carrying the C1494T mutation when compared to four
control cell lines. Furthermore, a significant decrease in the rate of total oxygen consumption was observed in the
mutant cell lines. Thus, our data strongly support the idea that the A site of mitochondrial 12S rRNA is the primary
target for aminoglycoside-induced deafness. These results also strongly suggest that the nuclear background plays
a role in the aminoglycoside ototoxicity and in the development of the deafness phenotype associated with the
C1494T mutation in the mitochondrial 12S rRNA gene.
Introduction
Hearing loss is a very common congenital disorder af-
fecting 1 in 1,000 newborns (Nance and Sweeney 1975;
Morton 1991). In the pediatric population, 150% of pa-
tients with deafness have a genetic predisposition, with
autosomal dominant, autosomal recessive, X-linked, or
mitochondrial patterns of inheritance (Petit et al. 2001;
Morton 2002). Deafness can result from a mutation in a
single gene or from a combination of mutations in dif-
ferent genes. Hearing loss can also be caused by environ-
mental factors, including perinatal infection, acoustic or
cerebral trauma affecting the cochlea, or ototoxic drugs,
such as aminoglycoside antibiotics, or it can be a result
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of interactions between genetic and environmental factors
(Petit et al. 2001; Morton 2002). Specifically, in familial
cases of ototoxic deafness, the aminoglycoside hypersen-
sitivity is often maternally transmitted, suggesting mito-
chondrial involvement (Fischel-Ghodsian 1999).
Mutations in mitochondrial DNA (mtDNA) have
been found to be associated with both aminoglycoside-
induced and nonsyndromic deafness (Fischel-Ghodsian
1999; Van Camp and Smith 2000). Among the identi-
fied nonsyndromic deafness-causing mtDNA mutations
are A7445G (Reid et al. 1994; Fischel-Ghodsian et al.
1995), 7472insC (Tiranti et al. 1995; Verhoeven et al.
1999), T7510C (Hutchin et al. 2000), and T7511C (Sue
et al. 1999) in the tRNASer(UCN) gene and the A1555G
mutation in the 12S rRNA gene (Prezant et al. 1993;
Estivill et al. 1998; Li et al. 2004). In particular, the
A1555G mutation has been found to be responsible for
nonsyndromic deafness in many families of different
ethnic backgrounds (Hutchin et al. 1993; Prezant et al.
1993; Matthijs et al. 1996; Estivill et al. 1998; Li et al.
2004). In the absence of exposure to aminoglycosides,
the A1555G mutation produces a clinical phenotype
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that varies considerably among family members, rang-
ing from severe congenital deafness, to moderate pro-
gressive hearing loss of later onset (Estivill et al. 1998;
Li et al. 2004), to completely normal hearing (Prezant et
al. 1993; Estivill et al. 1998; Li et al. 2004). More severe
biochemical defects were observed in the mutant lym-
phoblastoid cell lines derived from symptomatic individ-
uals from an Arab-Israeli family than from cell lines de-
rived from asymptomatic individuals in the same family
(Guan et al. 1996). These genetic and biochemical data
strongly indicate that the A1555G mutation is a primary
factor underlying the development of deafness and that
nuclear modifier genes play a role in modulating the phe-
notypic expression of the hearing loss associated with the
A1555G mutation (Guan et al. 1996, 2001; Li and Guan
2002; Li et al. 2002).
The A1555G mutation has been also found in a num-
ber of families and sporadic patients with aminoglyco-
side-induced severe or profound hearing loss (Hutchin et
al. 1993; Prezant et al. 1993; Estivill et al. 1998; Li et
al. 2004). This mutation lies in the conserved decoding
region of small ribosomal RNA, which is important for
the action of aminoglycosides (Moazed and Noller
1987; Purohit and Stern 1994). In fact, the new C1494-
1555G pair in 12S rRNA created by the A1555G mu-
tation facilitates the binding of aminoglycosides to mi-
tochondrial 12S rRNA (Hamasaki and Rando 1997).
Functional studies demonstrated a decrease in the
growth rates of lymphoblastoid cells derived from
symptomatic and asymptomatic members of the Arab-
Israeli pedigree (mentioned above) in the presence of a
high concentration of neomycin or paromomycin (Guan
et al. 1996, 2000). In addition, a C insertion or deletion
at position 961 of the 12S rRNA gene has been shown
to be associated only with aminoglycoside-induced
deafness (Bacino et al. 1995; Casano et al. 1999). These
data strongly indicate that the human mitochondrial
12S rRNA, particularly that carrying the A1555G mu-
tation, is the main ototoxic target for aminoglycoside
antibiotics.
The mutations at positions 1555 and 961 in the 12S
rRNA gene only account for a small portion of patients
with aminoglycoside-induced hearing impairment (Fis-
chel-Ghodsian 1999). Thus, it is anticipated that ad-
ditional mutations causing drug susceptibility can be
found in the same gene. Recently, a systematic and ex-
tended mutation screening of the mitochondrial 12S
rRNA gene has been initiated in the large clinical pop-
ulation of the otology clinic at the Chinese People’s
Liberation Army (PLA) General Hospital. As a conse-
quence of this study, 34 pedigrees with a maternally
inherited pattern of aminoglycoside-induced hearing
loss have been identified, including 15 pedigrees car-
rying the A1555G mutation in mitochondrial 12S
rRNA gene (Yuan et al. 1999; Li et al. 2001). In the
present study, we report the clinical, molecular, and ge-
netic characterization of a large Chinese family with
maternally transmitted aminoglycoside-induced and
nonsyndromic deafness (fig. 1A). Despite sharing some
common features, including bilateral, symmetric, and
sensorineural hearing loss, 39 matrilineal relatives in this
five-generation family exhibited the variable severity and
age at onset in hearing impairment. Molecular analysis
has led to the identification of a novel C-to-T transition
at position 1494 in the mitochondrial 12S rRNA gene.
The C1494T mutation is expected to form a new 1494-
1555 U-A base pair at the highly conserved A site of the
12S rRNA (Zimmermann et al. 1990; Neefs et al. 1991),
which is in the same position as the 1494-1555 C-G pair
caused by the A1555G mutation (Hutchin et al. 1993;
Prezant et al. 1993; Li and Guan 2002). To examine if
the C1494T mutation leads to aminoglycoside toxicity,
lymphoblastoid cell lines derived from six individuals of
the Chinese family (including four individuals exhibiting
both the mutation and hearing loss and two carrying the
mutation but lacking a clinical phenotype) and four ge-
netically unrelated controls lacking the mutation have
been analyzed for the sensitivity to drugs by exposure of
cells to a high concentration of paromomycin or neo-
mycin. Furthermore, the respiration capacity of those cell
lines was measured by determining the oxygen (O2) con-
sumption rate in intact cells.
Material and Methods
Patients
We ascertained a Chinese family (fig. 1A) through the
Department of Otolaryngology, Head and Neck Surgery,
Chinese PLA General Hospital. Informed consent, blood
samples, and clinical evaluations were obtained from all
participating family members, under protocols approved
by the Cincinnati Children’s Hospital Medical Center
institute review board and the Chinese PLA General
Hospital ethics committee. Members of this pedigree
were interviewed at length to identify either personal or
family medical histories of hearing loss, the use of ami-
noglycosides, and other clinical abnormalities. The 364
control DNA samples used for screening for the presence
of mtDNA mutations were obtained from a panel of
unaffected individuals from Chinese ancestry.
Audiological and Neurotological Examinations
The audiological and neurotological examinations of
the proband and other members of this family were con-
ducted, including pure-tone audiometry (Madsen GSI61),
immittance (Madsen GSI33), and auditory brain-stem re-
sponse (ABR) (IHS6002). The degree of hearing loss was
defined according to the pure-tone averages (PTA), which
were based on the three frequencies (500, 1,000, and
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2,000 Hz), as follows: normal !26 dB, mild 26–40 dB,
moderate 41–70 dB, severe 71–90 dB, and profound 190
dB.
Mutational Analysis of the Mitochondrial Genome
Genomic DNA was isolated from whole blood of par-
ticipants by use of the Puregene DNA Isolation Kits
(Gentra Systems). First, affected individuals’ DNA frag-
ments spanning the entire mitochondrial 12S rRNA gene
or tRNASer(UCN) gene were amplified by PCR using oli-
godeoxynucleotides corresponding to the mitochondrial
genome at positions 618–635 and 1589–1606 (Rieder
et al. 1998) and 7151–7170 and 8504–8623 (Fischel-
Ghodsian et al. 1995). For the detection of the A1555G
mutation, the amplified segments were digested with the
restriction enzyme BsmAI (Prezant et al. 1993; Guan et
al. 1996; Li et al. 2004). For the examination of A7445G
mutation, PCR fragments were digested with the restric-
tion enzyme XbaI (Fischel-Ghodsian et al. 1995; Guan
et al. 1998), whereas the presence of the T7511C mu-
tation was examined by digesting PCR products with
MboII (Sue et al. 1999).
The entire mitochondrial genome of the affected pa-
tient IV-21 was PCR amplified in 24 overlapping frag-
ments by use of sets of the light-strand and the heavy-
strand oligonucleotide primers, as described previously
(Rieder et al. 1998). Each fragment was purified and
subsequently analyzed by direct sequencing in an ABI
3700 automated DNA sequencer, using the BigDye Ter-
minator Cycle sequencing reaction kit. The BLAST ho-
mology searches were performed using the programs
available on the National Center for Biotechnology In-
formation Web site (Altschul et al. 1997). DNA and pro-
tein-sequence alignments were carried out using the
SeqWeb program GAP (GCG).
All family members and 364 controls were screened
for the presence of the C1494T mutation, by direct se-
quencing of a PCR product spanning bases 1245–2007.
Furthermore, the PCR products spanning bases 1245–
2007 in an affected member IV-21 and a control were
cloned into a PCR 2.1-TOPO vector (Invitrogen) and
then were directly sequenced. The allele frequency of
variants in 12S rRNA, 16S rRNA, ND1, ND4, and ND5
genes was determined by PCR amplification of frag-
ments spanning the corresponding regions, using the ge-
nomic DNA derived from Chinese controls as templates
and performing subsequent sequence analysis of PCR
products, as described above. These sequence results
were compared with the updated consensus Cambridge
sequence (Anderson et al. 1981).
Quantification of the Mitochondrial 12S rRNA C1494T
Mutation
Quantification of the C1494T mutation in the mito-
chondrial 12S rRNA gene was carried out by the allele-
specific termination of primer extension, as described
elsewhere (Bai and Attardi 1998). For this purpose, a
1,075-bp mtDNA segment at positions 697 and 1,771
was amplified by PCR reaction. The amplified fragment
was purified with the QIAEX II gel extraction kit (Qia-
gen). The PCR product was then used for allele-specific
primer-extension termination, using Sequenase (USB)
and the corresponding 32P-5′-end-labeled primer (Bai and
Attardi 1998). Nucleotide concentrations were 33 mM
dCTP and 500 mM ddTTP for the quantification of the
C insertion, and 33 mM dCTP, 33 mM dATP, and 500
mM ddTTP (USB) for the quantification of the C-to-T
mutation. The mixtures were heated to 95C for 2 min,
annealed at 50C for 10 min, and finally chilled on ice.
After the addition of Sequenase, they were incubated for
5 min at 45C. Electrophoretic analysis of the products
and quantification of the intensity of the bands were
carried out as described elsewhere (Bai and Attardi
1998). The primer used for primer extension was 5′-
GAAGCGCGTACACACCGCCCGT-3′.
Cell Cultures
Lymphoblastoid cell lines were immortalized by trans-
formation with the Epstein-Barr virus, as described else-
where (Miller and Lipman 1973). Cell lines derived from
six members of the Chinese family (two individuals [III-
14, III-16] with normal hearing, four affected individuals
[III-12, III-18, IV-21, IV-28]), and four genetically un-
related control individuals (A3, A6, A7, A8) were grown
in RPMI 1640 medium (Invitrogen), supplemented with
10% fetal bovine serum (FBS).
To test the various cell lines for sensitivity to paro-
momycin and neomycin, cells were grown for 4 d in
RPMI 1640 medium (Invitrogen), supplemented with
10% FBS, in the presence or absence of 2 mg of the
antibiotics per ml. The population doubling time (DT)
of the cell lines in RPMI 1640 medium, supplemented
with 10% FBS, was determined from the growth curves
or by using the formula DTp (t t ) log 2/(log N0
, where DT is the doubling time, t and t0 are thelog N )0
times at which the cells were counted, and N and N0
are the cell numbers at times t and t0, respectively (Guan
et al. 1996).
Oxygen Consumption Measurements
Rates of O2 consumption in intact cells were deter-
mined with a YSI 5300 oxygraph (Yellow Springs In-
struments) on samples of 1 # 107 cells in 1.5 ml of
special Dulbecco modified Eagle medium (DMEM) lack-
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Table 1
Summary of Clinical Data for Some Maternal Members of the Chinese Pedigree
PATIENT SEX
AGE
(years)
USE OF
AMINOGLYCOSIDES
PTAa
(dB)
LEVEL OF
HEARING
IMPAIRMENTAt Testing At Onset Right Ear Left Ear
II-4 F 81 165 No 42 37 Mild
II-6 F 78 165 No 35 32 Mild
II-9 F 74 165 No 42 35 Mild
II-11 M 68 24 Yes 90 82 Severe
III-2 F 60 50–60 No 40 42 Mild
III-4 M 58 50–60 No 80 32 Mild
III-8 F 50 40–50 No 37 43 Mild
III-10 F 45 … No 25 23 Normal
III-12 F 52 40–50 No 32 57 Mild
III-14 F 50 … No 22 27 Normal
III-16 F 46 … No 20 20 Normal
III-18 F 57 40–50 No 28 28 Mild
III-24 F 46 1–10 Yes 103 100 Profound
III-26 M 42 30 Yes 68 65 Moderate
IV-1 M 44 20–30 No 78 78 Severe
IV-13 F 26 1 Yes 107 102 Profound
IV-14 F 26 1 Yes 98 97 Profound
IV-16 M 21 10–20 No 27 27 Mild
IV-17 M 21 … No 22 18 Normal
IV-18 M 16 … No 23 20 Normal
IV-19 M 29 1.5 Yes 108 98 Profound
IV-21 M 26 1.5 Yes 91 91 Profound
IV-22 M 20 … No 22 18 Normal
IV-23 M 25 … No 13 13 Normal
IV-28 M 30 21 Yes 62 67 Moderate
IV-32 M 21 … No 23 22 Normal
V-8 M 1 … No NA NA Normal
a PTA p pure-tone averages.
ing glucose, supplemented with 10% dialyzed fetal bo-
vine serum (FBS) (King and Attardi 1989).
Computer Analysis
Statistical analysis was performed by the unpaired,
two-tailed Student t test contained in the Microsoft Excel
program for Macintosh (version 5).
Results
Clinical Presentation
The proband (IV-21) received streptomycin (0.75 g/d
for 3 d) for pneumonia at the age of 18 mo. He began
suffering bilateral hearing impairment 3 d after therapy.
He came to the otology clinic at the Chinese PLA General
Hospital at the age of 26 years. As illustrated in figure
1B, the audiological evaluation, including the pure-tone
audiometry, immittance, and ABR, showed that he had
profound hearing loss. Karyotype analysis and a CT scan
of temporal bones were normal. In addition, he had no
other significant medical history.
The family originated from Liaoning Province in
northeastern China, and the majority of family members
live in the same area. As shown in figure 1, this familial
history is consistent with maternal inheritance. None of
the offspring of deaf fathers has a hearing impairment,
whereas 20 of 39 matrilineal relatives, who are the off-
spring of subject I-1, exhibit bilateral and sensorineural
hearing impairment as the sole clinical symptom. All
affected individuals showed the loss of high frequencies.
In 18 of the 20 affected subjects, hearing impairment
was symmetric. Of two individuals with asymmetric
hearing impairment, the more severe dysfunction in the
left ear of III-12 was due to otitis media at the age of
34 years and the severe defect in the right ear of III-4
was due to sudden deafness at the age of 50 years. In
the absence of aminoglycosides, matrilineal relatives of
this family exhibited late-onset/progressive, but not con-
genital, hearing impairment. As shown in table 1, au-
diometric studies showed a variable severity of hearing
impairment in the maternal kindred, ranging from severe
hearing impairment, to moderate hearing impairment,
to mild hearing impairment, to completely normal hear-
ing. In addition, there was a wide range in the age at
onset of hearing impairment in this family, varying from
10 years to 65 years. Notably, the average age at onset
of hearing impairment in this family, excluding matri-
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lineal relatives who had a history of exposure to ami-
noglycosides, has changed from 55 years (generation II)
to 10 years (generation IV).
As shown in table 1 and figure 1, eight matrilineal
relatives of this family, who had a history of exposure
to gentamicin and/or streptomycin had subsequent mod-
erate-to-profound hearing loss. Hearing impairment
usually occurred 3 d after injection. The age at the time
of administration varied among those individuals. Five
individuals (III-24, IV-13, IV-14, IV-19, and IV-21) who
received a regular dose of aminoglycosides (3–5 mg/kg/
dose every 8 h for gentamicin or 15–25 mg/kg/dose every
12 h for streptomycin) at !10 years of age developed
profound hearing loss. By contrast, three other individ-
uals (II-11, III-26, and IV-28) suffered moderate-to-se-
vere hearing loss after administration of a regular dose
of aminoglycosides at 120 years of age. In particular,
the subject IV-28 had mild hearing impairment at the
age of 20 years. After administering a regular dose of
gentamicin (80 mg/dose every 12 h) for appendicitis at
the age of 21 years, he suffered moderate hearing loss
(fig. 1B). Clearly, the age at the time of drug adminis-
tration appears to be correlated with the severity of the
hearing loss experienced by affected individuals.
There is no evidence that any member of this family
had any other known cause to account for hearing im-
pairment. Comprehensive family medical histories of
these individuals showed no other clinical abnormalities,
including diabetes, muscular diseases, visual problems,
and neurological disorders. Furthermore, these matrilin-
eal relatives, who were examined by karyotype analysis
and a CT scan of temporal bones, revealed no abnormal
findings.
Mitochondrial DNA Analysis
The maternal transmission of aminoglycoside-induced
and nonsyndromic hearing loss in this family suggested
mitochondrial involvement and led us to analyze the
mitochondrial genome of matrilineal relatives. First, we
examined the known mtDNA mutations associated with
deafness by PCR amplification and subsequent restric-
tion-enzyme digestion analysis of PCR fragments derived
from four matrilineal relatives (the deaf proband [IV-
21], his deaf mother [III-12], an unaffected female [III-
14], and an affected male [IV-28]) and two unrelated
Chinese controls. We failed to detect either the presence
of A1555G mutation in the 12S rRNA gene or the
A7445G, T7510C, and T7511C mutations in the t-
RNASer(UCN) gene in those patients.
To elucidate the molecular basis for the mutations
found in this family with maternally transmitted deaf-
ness, 24 overlapping DNA fragments spanning the entire
mitochondrial genome of proband (IV-21) were PCR
amplified and each fragment was purified and subse-
quently analyzed by DNA sequencing. The comparison
of the resultant sequence with the Cambridge consensus
sequence (Anderson et al. 1981) identified a number of
nucleotide changes, as shown in Table 2. All of those
nucleotide changes were verified in 12 additional mat-
rilineal relatives of this family (6 symptomatic and 6
asymptomatic individuals) by sequence analysis and ap-
peared to be in homoplasmic form.
Of these nucleotide changes, there are three variants
in the 12S rRNA gene and three variants in the 16S
rRNA gene, as mitochondrial rRNAs were proposed to
be the target sites for aminoglycoside otoxicity. The
A663G mutation in the 12S rRNA gene and the A1736G
mutation in the 16S rRNA gene were previously iden-
tified in the control population (Kogelnik et al. 1998),
whereas the 961insC in the 12S rRNA gene has been
implicated to have a role in the phenotypic expression
of A1555G mutation (Li et al. 2004). On the other hand,
the C1494T mutation in the 12S rRNA gene (fig. 2A)
and the G1709A and C2572G mutation in the 16S
rRNA gene appear to be novel variants. These variants
were then examined to determine the frequency in the
Chinese control population by sequencing the PCR frag-
ments spanning the 12S rRNA and 16S rRNA genes,
derived from the Chinese controls. As shown in table
2, the C1494T mutation was absent in 364 controls,
whereas other variants in the 12S rRNA and 16S rRNA
gene occurred in the Chinese controls. To determine if
the C1494T mutation is present in homoplasmic form in
the matrilineal relatives and controls, a more sensitive
experiment, involving allele-specific termination of primer
extension, was carried out. As can be seen in figure 2B,
there is no detectable wild-type DNA in the six mutant
individuals, indicating that the C1494T mutation ap-
pears to be homoplasmic. Furthermore, the PCR prod-
ucts spanning bases 1245–2007 in an affected family
member (IV-21) and a control were cloned into a PCR
2.1-TOPO vector (Invitrogen) and then were directly
sequenced. Sequence data showed that all 16 clones de-
rived from patient IV-21 contain the C1494T mutation,
whereas 16 clones derived from a control lack the
C1494T mutation. Further analysis showed that this
mutation was present in all matrilineal relatives of this
family in the homoplasmic form. These variants in the
rRNA genes were further evaluated by phylogenetic
analysis of these mtDNA variants and mtDNAs from
other organisms. The five variants in the 12S rRNA and
16S rRNA genes were not highly conserved, whereas the
C1494T mutation in the 12S rRNA is localized at a
highly evolutionarily conserved site from bacteria to ver-
tebrate, including human (Anderson et al. 1981), mouse
(Bibb et al. 1981), bovine (Gadaleta et al. 1989), and
Xenopus laevis (Roe et al. 1985). As shown in figure 3,
the C at position 1494 (equivalent to C at position 1409
of Escherichia coli 16S rRNA) is localized at the highly
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Table 2
mtDNA Mutations in the Chinese Pedigree
Gene and Position Mutation
Conservation
in H/B/M/Xa Frequencyb
Previously
Reportedc
D-Loop:
73 ArG NA Yes
235 ArG NA Yes
263 ArG NA Yes
310 TrCTC NA Yes
515 AC deletion NA Yesd
16223 CrT NA Yes
16290 CrT NA Yes
16319 GrA NA Yes
16362 TrC NA Yes
12S rRNA:
663 ArG 6/364 Yesd,e
961 C insertion 4/364 Yesd
1494 CrT C/C/C/C 0/364 No
16S rRNA:
1709 GrA G/G/T/T 1/108 No
1736 ArG A/T/C/A 2/108 Yesc,d
2572 CrG C/C/C/G 1/108 No
ND1:
4247 TrC (Ile to Thr) I/I/V/L 1/108 No
ND2:
4769 ArG NA Yes
4824 ArG (Thr to Ala) T/T/T/L NA Yes
CO1:
7028 CrT NA Yes
A6:
8794 CrT (His to Tyr) H/H/H/Y NA Yes
8860 ArG (Thr to Ala) T/A/A/T NA Yes
ND4:
11639 ArC (Met to Leu) M/M/M/M 1/108 No
11718 GrA (Gly to Glu) G/G/G/G NA Yes
ND5:
12705 CrT NA Yes
14075 ArC (Gln to Pro) Q/Q/Q/Q 1/108 No
cytochrome b:
15326 ArG (Thr to Ala) T/M/I/I NA Yes
a Conservation of amino acid for polypeptides or nucleotide for rRNAs, in human
(H), bovine (B), mouse (M), and Xenopus laevis (X).
b Numbers of controls with mutation/total controls.
c See the online mitochondrial genome database MITOMAP.
d Li et al. 2004.
e Prezant et al. 1993.
conserved A site of human mitochondrial 12S rRNA
(Zimmermann et al. 1990; Neefs et al. 1991), which is
the main target site for aminoglycoside otoxicity (Moa-
zed and Noller 1987; Purohit and Stern 1994). The C-
to-U transition at position 1494 in this Chinese family
would be base-paired with A at position 1555 of A site
of the 12S rRNA. This new U-A pair, located at the same
position as the C-G base pair generated by the deafness-
associated A1555G mutation, is expected to create a new
binding site for aminoglycosides, as described in a study
of E. coli (De Stasio and Dahlberg 1990), thus causing
the sensitivity to these drugs.
Of the other nucleotide changes in this mitochondrial
genome, nine variants in the D-loop region and eight
variants in the protein encoding genes were previously
found in the Chinese control population (Kogelnik et al.
1998; Li et al. 2004). Furthermore, the T4247C (I314T)
mutation in the ND1 gene, the A11639C (M294L) mu-
tation in the ND4 gene, and the A14075C (G580P) mu-
tation in the ND5 gene are probably novel missense
polymorphisms in the Chinese population. As shown in
table 2, sequencing analysis of the PCR fragments span-
ning the ND1, ND4, and ND5 genes revealed that these
variants indeed occur in the Chinese control population.
Furthermore, the I314T mutation in the ND1 gene was
not highly conserved, whereas the M294L mutation in
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Figure 2 Identification and qualification of C1494T mutation
in the mitochondrial 12S rRNA gene. A, Partial-sequence chromato-
grams of the 12S rRNA gene from an affected individual, IV-21, and
a married-in control, III-13. An arrow indicates the location of the
base changes at position 1494. B, Quantification of C1494T mutation
in the 12S rRNA gene of individuals with mutations and controls
derived from the Chinese family. Allele-specific termination of primer
extension was carried out as detailed in the “Material and Methods”
section. The products were separated on a 20% polyacrylamide/7M
urea sequence gel.
the ND4 gene and the M294L mutation in the ND5
gene are localized at sites that are highly conserved in
human (Anderson et al. 1981), mouse (Bibb et al. 1981),
bovine (Gadaleta et al. 1989), and Xenopus (Roe et al.
1985).
Effect of Aminoglycosides on the Growth of Cell Lines
Carrying the C1494T Mutation
To examine the role of the C1494T mutation in the
effect of aminoglycosides on cell growth, lymphoblas-
toid cell lines derived from six individuals carrying the
C1494T mutation and from four genetically unrelated
Chinese controls were grown in RPMI 1640 medium in
the presence of drugs, or in their absence, for 4 d. As
shown in figure 4, in the presence and absence of 2 mg
paromomycin or 2 mg neomycin per ml, the growth rates
of the mutant cell lines carrying the C1494T mutation
exhibited a significant average decrease, relative to the
growth rates of control cell lines. In particular, in the
mutant cell lines carrying the C1494T mutation, the ra-
tios of doubling times (DT) in the presence and absence
of paromomycin were increased by an average of 24%
 7% (standard error of the mean [SEM]), relative to
the average DT ratio in the control cell lines ( ).Pp .01
However, the sensitivity to paromomycin among those
cell lines varied greatly: patient III-18 exhibited a DT
ratio comparable with the mean control value, and pa-
tient IV-28 showed a 55% increase in DT ratio, relative
to the average DT ratio in controls. Similarly, the DT
ratios of mutant cell lines carrying the C1494T mutation
in the presence and absence of the neomycin were in-
creased by an average of 18%  5% (SEM), relative to
the average DT ratio in the control cell lines ( ).Pp .02
Among these mutant cell lines, III-18 had a DT ratio
comparable with the mean control value, whereas pa-
tient IV-28 displayed a 43% increase in DT ratio, relative
to the average DT ratio in controls. From these data,
we conclude that the C1494T mutation plays a role in
the sensitivity to aminoglycoside of the growth rate of
the cell lines derived from matrilineal relatives in this
Chinese pedigree.
Oxygen Consumption Rate Measurements
The endogenous respiration rates of lymphoblastoid
cell lines derived from two asymptomatic individuals
and from four symptomatic individuals of the Chinese
family carrying the C1494T mutation and from four
genetically unrelated Chinese controls were measured by
determining the O2 consumption rate in intact cells, as
described by King and Attardi (1989). As can be seen
in figure 5, the rate of total O2 consumption in six mu-
tant lymphoblastoid cell lines exhibited a variable de-
crease, ranging from ∼11% to ∼27%, relative to the
mean value measured in the control cell lines, with an
average reduction of ∼19% ( ). In particular,Pp .0109
a ∼24% average reduction in the rate of total O2 con-
sumption was observed in two lymphoblastoid cell lines
derived from the asymptomatic individuals that exhib-
ited a variable decrease, relative to the mean value mea-
sured in the control cell lines, whereas the four lym-
phoblastoid cell lines from the symptomatic individuals
also displayed a variable reduction in the rate of O2
consumption, ranging from 11% to 21%, when com-
pared with the mean control value, with a ∼17% average
reduction.
Discussion
In the present study, we have performed the clinical,
genetic, and molecular characterization of a large Chi-
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Figure 3 The site of the C1494T mutation in the decoding region of small ribosomal RNAs. The A site of the E. coli 16S rRNA
oligonucleotide showing the dimethyl sulfate (DMS) footprints, observed in the presence of the aminoglycosides neomycin and paromomycin
(Moazed and Noller 1987; Purohit and Stern 1994), is marked with a dot (A). The corresponding region of human mitochondrial 12S rRNA
is shown as the wild-type version (B) (Li and Guan 2002) and in the version containing the A1555G mutation (C) and C1494T mutation (D).
The sites for the A1555G and C1494T mutations are indicated by arrows.
nese family with aminoglycoside-induced and nonsyn-
dromic hearing loss. The clinical phenotypes, including
aminoglycoside-induced and nonsyndromic hearing im-
pairment, were only present in the maternal lineage of
this five-generation pedigree, suggesting that the mtDNA
mutation is the molecular basis for this disorder. Here,
we have identified a homoplasmic C-to-T transition at
position 1494 in the mitochondrial 12S rRNA gene. The
following evidence suggests that the C1494T mutation is
a primarily pathogenic mtDNA mutation that causes a
genetic predisposition to aminoglycoside ototoxicity and
nonsyndromic deafness. This mutation is present only in
matrilineal relatives of this family in the homoplasmic
form, and not in the 364 Chinese controls. The C1494T
mutation is localized at the A site of the mitochondrial
12S rRNA (Moazed and Noller 1987; Zimmerman et
al. 1990; Neefs et al. 1991; Purohit and Stern 1994),
which has been implicated to be associated with ami-
noglycoside ototoxicity (Prezant et al. 1993; Hamasaki
and Rando 1997). The phylogenetic analysis of this mu-
tation and mtDNAs from other organisms revealed that
the nucleotide C at the position 1494 in the decoding
region of 12S rRNA was extremely evolutionarily con-
served from bacteria to human mitochondria (Zimmer-
man et al. 1990; Neefs et al. 1991). Finally, lympho-
blastoid cell lines derived from members of the Chinese
family carrying the C1494T mutation, compared with
the wild-type cell lines, exhibited a significant reduction
in the growth rate in the presence of a high concentration
of paromomycin or neomycin, as well as in the rate of
total O2 consumption.
The region of 16S rRNA in E. coli, corresponding to
that of the human 12S rRNA C1494T mutation, forms
an essential part of the decoding site of the ribosome
(De Stasio and Dahlberg 1990; Zimmermann et al.
1990) and is crucial for subunit association either by
RNA-protein or RNA-RNA interactions (Zwieb et al.
1986). Furthermore, the sensitivity to paromomycin,
neomycin, and related aminoglycosides in bacteria in-
volves their direct binding to a C-G base pair at posi-
tions 1409–1491 of the penultimate helix in the small
ribosomal subunit rRNA (fig. 3) (Moazed and Noller
1987; Purohit and Stern 1994). In particular, in wild-
type E. coli sensitive to these aminoglycosides, the nu-
cleotide at position 1491 (G) in 16S rRNA is base-paired
with a C at position 1409; mutation or methylation of
the 1491 nucleotide disrupts the G-C pairing, producing
resistance to aminoglycosides (Li et al. 1982; Spangler
and Blackburn 1985; De Stasio and Dahlberg 1990).
On the other hand, the reverse mutations C1409U-
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Figure 4 Growth properties of lymphoblastoid cell lines. The
population doubling time (DT) during 4 d of growth was determined
in RPMI 1640 medium in the presence and absence of paromomycin
(a) and neomycin (b). The ratios of DTs in the presence and absence
of 2 mg paromomycin or neomycin per ml are shown. The average
of four to five determinations for each cell line is shown, with error
bars representing 2 SEM. The horizontal dashed lines represent the
average value for each group; P indicates the significance, according
to the Student t test, of the differences between the mutant mean and
the control mean.
Figure 5 Respiration assays. Average rates of endogenous O2
consumption per cell measured in different lymphoblastoid cell lines
are shown, with error bars representing 2 SEM. Five to seven deter-
minations were made for each cell line. The graph details and symbols
are explained in the legend to figure 4.
G1491A, which create the new U-A pairing in the E.
coli 16S rRNA, also confer sensitivity to a variety of
aminoglycoside antibiotics, including paromomycin
and neomycin (De Stasio and Dahlberg 1990). In human
mitochondria, the nucleotide at position 1555 (corre-
sponding to position 1491 in E. coli 16S rRNA) in wild
type is A, which would be expected to pair with the C
at position 1494 (Prezant et al. 1993; Li and Guan
2002) but instead mutates to a G, as in the Arab-Israeli
and other families. It makes the secondary structure of
the 12S rRNA similar to the corresponding region of
the E. coli 16S rRNA (Prezant et al. 1993), thus facil-
itating the binding and sensitivity to aminoglycosides
(Guan et al. 1996, 2000; Hamasaki and Rando 1997)
and causing defects in mitochondrial protein synthesis
and respiration (Guan et al. 1996, 2001). In the case
of this Chinese family, the C-to-T transition at position
1494 in the human 12S rRNA (equivalent to position
1409 in the E. coli 16S rRNA) would be expected to
pair with the A at position 1555. The new U-A base
pair created by the C1494T mutation, corresponding
to the U-A pairing at positions 1409–1491 in the E.
coli 16S rRNA, was anticipated to lead to the binding
and sensitivity to aminoglycosides. This alteration in the
tertiary structure of the 12S rRNA may result in the
impairment of mitochondrial protein synthesis. As a
consequence, the C1494T mutation in the mitochon-
drial 12S rRNA produces a respiratory deficiency and
could subsequently result in a decline in ATP production
in the cochlear cells (hair cells and/or stria vascularis),
which are essential for hearing function (Prezant et al.
1993; Guan et al. 1996).
Table 3 shows the aminoglycoside sensitivity and res-
piration defect detected in a previous analysis of the
A1555G mutation and in the present work for the
C1494T mutation. The rate of O2 consumption of
the lymphoblastoid cell lines derived from 10 symptom-
atic and 9 asymptomatic members of the Arab-Israeli
family carrying the A1555G mutation revealed an av-
erage reduction of 30% and 25%, relative to the mean
values measured in wild-type cell lines (Guan et al.
1996). In the present work, ∼17% and ∼24% average
reductions in the rate of oxygen consumption were ob-
served in the lymphoblastoid cell lines derived from four
symptomatic and two asymptomatic individuals of the
Chinese family carrying the C1494T mutation, respec-
tively. Notably, there was the small difference in en-
dogenous respiration rate between two groups of cell
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Table 3
Oxygen Consumption Rate and DT Ratio in the Presence and Absence of Aminoglycosides of Lymphoblastoid Cell Lines Carrying the
A1555G and C1494T Mutations
RATE OR RATIO
AVERAGE VALUE  SD IN A1555G CELL LINES,
RELATIVE TO CONTROLSa,b
(%)
P FOR
A1555G
CELL
LINES
AVERAGE VALUE  SD IN C1494T CELL LINES,
RELATIVE TO CONTROLS
(%)
P FOR
C1494T
CELL
LINESAsymptomatic Individuals Symptomatic Individuals Asymptomatic Individuals Symptomatic Individuals
O2 consumption rate 759 708 .4558 764 836 .0954
DT ratio (/ paromomycin) 1383 1374 .8542 1215 1238 .8486
DT ratio (/ neomycin) 1325 1429 .3284 1236 12511 .8473
NOTE.—P p the significance, according to the Student t test, of the differences between the symptomatic and asymptomatic means. The presence/absence of
aminoglycosides is denoted by /.
a Guan et al. 1996, 2000.
b Guan, unpublished data.
lines. These strongly indicate that the C1494T mutation
produces a milder biochemical defect than that of the
A1555G mutation. A comparison between the DT ra-
tios of presence and absence of paromomycin or neo-
mycin in the lymphoblastoid cell lines derived from mat-
rilineal relatives of the Chinese family carrying the
C1494T mutation and those of the Arab-Israeli family
carrying the A1555G mutation revealed that the cell
lines carrying the C1494T mutation have less sensitivity
to drugs than those carrying the A1555G mutation.
These results are in agreement with the fact that the E.
coli strains carrying the C1409U-G1491A mutation in
the 16S rRNA exhibited less sensitivity to aminogly-
cosides than those carrying the wild-type 1409C-1491G
pair at the A site of 16S rRNA (De Stasio and Dahlberg
1990). These data strongly suggest that sensitivity to
aminoglycosides in the cell lines appears to be depen-
dent on the presence of the mitochondrial 12S rRNA
C1494T mutation. In contrast to the pedigrees carrying
the A1555G mutation, the age at the time of drug ad-
ministration has been shown to be correlated with the
severity of the hearing loss experienced by affected in-
dividuals in this Chinese family. Furthermore, the con-
siderable variability in sensitivity to aminoglycosides
was observed among the six cell lines derived from this
Chinese pedigree. These data are strong evidence that
aminoglycosides can induce or worsen the deafness phe-
notype associated with the C1494T mutation. These
observations also provide the first direct evidence that
other factors, specifically in a nuclear background, play
a role in the sensitivity to the drugs in those individuals
carrying the C1494T mutation.
The fact that only a portion of patients with the
C1494T mutation developed hearing impairment (31%
penetrance when the effect of aminoglycosides was ex-
cluded, but 51% penetrance when aminoglycoside-in-
duced deafness was included) in this Chinese family
clearly indicates that the C1494T mutation alone is not
sufficient to produce the clinical phenotype. As in the
families carrying the A1555G mutation (Prezant et al.
1993; Li et al. 2004), the matrilineal relatives in this
Chinese pedigree displayed phenotypic variability, in-
cluding in the severity and age at onset in the absence
of aminoglycosides. In particular, the members of the
Chinese family with the C1494T mutation always ex-
hibited progressive and/or later-onset hearing impair-
ment, whereas the hearing impairment of members in
the Arab-Israeli family carrying the A1555G mutation
was mainly congenital (Prezant et al. 1993). This dis-
crepancy likely reflects the difference between the ge-
netic backgrounds of the Arab-Israeli and Chinese fam-
ily. The other striking clinical feature in the Chinese
family is that the average age at onset of hearing
impairment in this family, excluding matrilineal rela-
tives who had a history of exposure to aminoglycosides,
has changed from 55 years (generation II) to 10 years
(generation IV). These observations strongly suggest the
involvement of nuclear modifier genes in the develop-
ment of the deafness phenotype associated with the
C1494T mutation, similar to that in the Arab-Israeli
family carrying the A1555G mutation (Prezant et al.
1993; Guan et al. 1996, 2000). Furthermore, it is pos-
sible that other environmental factors, besides aminog-
lycosides, may contribute to the penetrance of the
C1494T mutation, especially in late-onset cases, in this
family. The products of a putative nuclear gene, which
may functionally interact with mutated 12S rRNA,
could enhance the effect of the C1494T mutation to
produce the hearing impairment or to suppress it (Guan
et al. 1996).
Furthermore, mitochondrial haplotypes have been im-
plicated in influencing the penetrance of the primary
mtDNA mutations. For instance, mtDNA mutations at
positions 4216 and 13708 can increase the penetrance
of the primary Leber hereditary optic neuropathy
(LHON) mutations, including the 11778 mutation in the
ND4 gene, the 14484 mutation in the ND6 gene (Wallace
et al. 1988; Howell et al. 1991; Torroni et al. 1997), and
the deafness-linked A7445G mutation in the precursor
of tRNASer(UCN) gene (Guan et al. 1998). In this Chinese
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family, several mtDNA mutations may also play a role
in the deafness phenotypic manifestation of the C1494T
mutation. In particular, the C insertion at position 961
was found to coexist with the C1494T mutation in this
family. Despite a lack of biochemical evidence, genetic
data have indicated that the mutations in 961 are as-
sociated only with aminoglycoside ototoxicity (Bacino
et al. 1995; Casano et al. 1999). It has been suggested
that the C insertion at position 961 may enhance the
biochemical defect associated with the A1555G mu-
tation, thus increasing the age at onset, as well as the
severity of hearing impairment, in the large Chinese
family (Li et al. 2004). Here, the cosegregation of the
961 C insertion with the C1494T mutation in the 12S
rRNA gene in this family also raises the possibility that
the 961 mutation may play a role in the phenotypic
manifestation of the C1494T mutation. Other muta-
tions, showing high evolutionary conservation, in-
cluding the M294L mutation in the ND4 gene and the
M294L mutation in the ND5 gene, may also contribute
to the penetrance of the C1494T mutation in this large
Chinese family.
In conclusion, the results reported here convincingly
demonstrate that the C1494T mutation in the 12S
rRNA gene is a novel primary mtDNA mutation as-
sociated with both aminoglycoside-induced and non-
syndromic deafness. This mutation is clearly not suffi-
cient to produce the clinical phenotype, since several
individuals who are carrying the mutation have normal
hearing. Other factors, including nuclear modifier
genes, mitochondrial haplotypes, and aminoglycosides,
contribute to the penetrance and expressivity of deaf-
ness associated with the C1494T mutation in this Chi-
nese large family. Specifically, our data strongly support
the idea that the A site of mitochondrial 12S rRNA is
the primary target for aminoglycoside ototoxicity. In
addition, our results also provide the first direct evi-
dence that the nuclear background plays a role in the
sensitivity to the aminoglycosides in those individuals
carrying the C1494T mutation in the mitochondrial 12S
rRNA gene.
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